Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Fatigue Following Cancer Therapy
NCT02317341Phase 1Terminated
- Sponsor
- National Institute of Nursing Research
- Start
- Dec 2014
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketamine in fatigue (2 arms), sponsored by National Institute of Nursing Research. Primary endpoint: Functional Assessment of Cancer Therapy-Fatigue at 14 days. Started Dec 2014; status: terminated.
02
Drugs
ketamine
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT02317341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02317341.